Literature DB >> 709891

Autoimmune thyroid disease and the polymyalgia rheumatica-giant cell arteritis syndrome.

R G Dent, O M Edwards.   

Abstract

In a study of 250 patients with autoimmune thyroid disease, seven (2.8%) were found to have polymyalgia rheumatica or giant cell arteritis. All cases occurred in female patients over the age of 60 years, a prevalence in this group of 9.3%. No cases of either disorder were seen in a control population of 150 female patients over the age of 50 years attending a cardiac clinic at the same hospital. Awareness of this association may allow earlier diagnosis and treatment of this syndrome in elderly patients with thyroid disease.

Entities:  

Mesh:

Year:  1978        PMID: 709891     DOI: 10.1111/j.1365-2265.1978.tb02202.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

1.  Association between giant cell arteritis and thyroid dysfunction in a "real life" population.

Authors:  Yarden Yavne; Shmuel Tiosano; Abdulla Watad; Doron Comaneshter; Yehuda Shoenfeld; Arnon D Cohen; Howard Amital
Journal:  Endocrine       Date:  2017-06-16       Impact factor: 3.633

2.  Giant cell arteritis in a patient with acute aortic insufficiency with thyrotoxicosis.

Authors:  Rajive Tandon; Ruairi Fahy
Journal:  Clin Rheumatol       Date:  2005-05-18       Impact factor: 2.980

3.  The spectrum of thyroid disorders in systemic lupus erythematosus.

Authors:  Kundan Kumar; Alakes Kumar Kole; Partha Sarathi Karmakar; Alakendu Ghosh
Journal:  Rheumatol Int       Date:  2010-07-25       Impact factor: 2.631

4.  Thyroid dysfunction and rheumatic diseases.

Authors:  J P Delamere; D L Scott; D D Felix-Davies
Journal:  J R Soc Med       Date:  1982-02       Impact factor: 5.344

5.  Thyroid disorders in Chinese patients with systemic lupus erythematosus.

Authors:  R T Tsai; T C Chang; C R Wang; C Y Chuang; C Y Chen
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.